AKT2 and neoplasm: AKT1 and AKT2 genes enhance tumor growth by promoting epithelial-to-mesenchymal transition (EMT) through PI3K activation [16,17], and the tumor suppressor gene of the PTEN antagonist PI3K/AKT pathway induces AKT-regulated tumor metastasis through loss-of-function mutations [18].